🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

.BigHat Biosciences's latest deal with J&J will help position the AI-guided antibody designer to move its internal pipeline toward the clinic. BioCentury's Paul Bonanos speaks with the company's leadership. Johnson & Johnson buff.ly/3w53ZVa

We’re excited to collaborate with BigHat Biosciences to leverage the power of #ArtificialIngellience and #MachineLearning to advance #DrugDiscovery with a focus on engineering antibodies to help tackle difficult-to-treat diseases in neuroscience: bit.ly/3Qg7Bui

Danielle Landrein, Director of Talent & Culture at BigHat, has been appointed to the Strategic Advisory Board of the LEAP HR TA Searchlight network, alongside colleagues from Alkermes, Novartis, and Bristol Myers Squibb. Danielle will serve on the Advisory Board to provide valuable

We welcome Noelle, Mimi and Kevin to BigHat! Kevin Lei joins us as Associate Director of Business Development. He will spearhead our efforts with prospective partners, external relations, competitive intelligence, and opportunity assessments of NTCs. Kevin brings a diverse set

Elizabeth Schwarzbach, CBO of BigHat, will join Ariel Katz (CEO & Co-Founder, H1) and Ginger Liau (Partner, a16z Bio + Health) for a panel discussion: “How AI is Transforming Pharmaceutical R&D” moderated by Dave Apfel (Head, External Innovation, R&D Data Science and Digital

We welcome Monique, Somnath, and Josh! Monique joins us as a Scientist I as part of the Platform Biology team at BigHat. Monique will lead high-throughput Discovery cell-based productionization, spearheading cell line onboarding, cell-based assay validation, and characterization

We welcome Tiffany, Eman and Meg! Tiffany joins us as a Senior Software Engineer I on the Lab Systems engineering team. She will be focusing on projects aimed at deepening our integration with the lab and our proprietary LIMS, Reccy. Tiffany is a full-stack software engineer

🏔️ Join us in supporting Peyton Greenside from the BigHat team as she takes on the Timmerman Traverse for Sickle Forward! 🌍✨ This September, Peyton will hike to the summit of Mt. Kilimanjaro (19,340 ft / 5,895 m) to raise funds for Sickle Cell Disease (SCD) diagnosis and

BigHat’s Chief Business Officer, Elizabeth Schwarzbach, joined Judy Khan Shaw on #NYSEFloorTalk to discuss BigHat’s mission and cutting-edge approach to drug discovery, which combines AI and ML with a rapid and high-quality laboratory to develop next-gen antibodies on our Milliner™

We welcome Mira, Ian and Sichen to BigHat! Mira Markova joins us as Scientist II, Platform. Mira will lead internal cell-line development and engineering efforts at BigHat, supporting our Programs and Discovery needs. Mira received her B.S. in France, and M.S. split between

🚀 Exciting News! 🚀 We are thrilled to announce that BigHat Biosciences has been featured on 2024’s FierceBiotech 15! This prestigious recognition highlights our fierce approach in leveraging machine learning and synthetic biology for high quality antibody drug discovery. A

We’re excited to share that BigHat Biosciences was featured in Genetic Engineering & Biotechnology News. Our co-founder and CSO, Peyton Greenside, discussed how AI is advancing traditional antibody engineering by leveraging diverse antibody sequences, modeling multiple properties simultaneously, and generating

We welcome Anisha, Crystal and Vanessa! Anisha joins us as a Senior Data Scientist II. Anisha will be focusing on supercharging data analysis and visualization in our proprietary LIMS, Reccy. Anisha earned her BS in Aerospace Engineering and Applied Math at UCLA and her PhD in

Elizabeth Schwarzbach, CBO of BigHat, will join Atomic AI , Compass Pathways, ZS and DeepCure for a panel discussion: “Maximizing Returns: Unleashing the Power of AI for Tangible ROI” at the 7th LSX Leaders 2024 on September 11, 2024 3:50 pm EST.

We welcome Sayantan Mitra, Isabella Bangs and Tim Randle! Sayantan joins us as Director, Protein Sciences. Sayantan will be focusing on scaling BigHat’s Protein Sciences team and setting an ambitious technical roadmap supporting the mission of advancing BigHat’s state-of-the-art

🌟 A BIG Thank You! Peyton Greenside Summits Kilimanjaro for Sickle Forward! 🏔️🎉 We are thrilled to announce that BigHat’s Cofounder and CSO, Peyton Greenside has successfully completed the Timmerman Traverse, summiting Mt. Kilimanjaro along with 20 other team members to raise

We welcome Diana, Rima and Helena! Diana David joins us as Executive Administrator to BigHat’s Corporate Dev & Ops team. Diana will support BigHat’s Leadership, Business Development, and Recruiting related administrative activities. After over two years of incredible work with

We’re thrilled to announce that Charbel Eid, VP of Platform at BigHat Biosciences, will be giving an invited talk at the upcoming LabAutomation (LRIG) event! Charbel will be sharing insights into how BigHat is revolutionizing the development of next-generation antibody therapeutics through

We’re excited to share that Liz Schwarzbach, CBO of BigHat Biosciences, will be participating in a panel at Tough Tech Week 2024, titled Partnering for Speed & Progress in Human Health. In this discussion, Liz will draw on her experience to highlight how partnerships are